BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

PHARMAID

All Eps Dividend Board Agm Q1 Q2 Q3

PHARMAID 24-Jan-2018

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2018 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2017.

PHARMAID 12-Nov-2017

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2017 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2017.

PHARMAID 12-Nov-2017

The Board of Directors has recommended 35% cash dividend for the year ended on June 30, 2017. Date of AGM: 28.12.2017, Time: 11:00 AM, Venue: Kendrio Kanchi Kancher Mela Auditorium, 37/A Segun Bagicha, Dhaka-1000. Record date: 04.12.2017. The Company has also reported EPS of Tk. 9.48, NAV per share of Tk. 49.53 and NOCFPS of Tk. 4.09 for the year ended on June 30, 2017 as against Tk. 7.52, Tk. 43.24 and Tk. 6.39 respectively for the same period of the previous year.

PHARMAID 01-Nov-2017

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 09, 2017 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2017.

PHARMAID 08-Oct-2017

The Company has informed that the Board of Directors has been taken a decision for importing one Set of Brand New Machinery with Finishing Line from Europe for a total value of Tk. 2.36 crore (approx) for manufacturing Neutral Glass Ampoules.

PHARMAID 25-Apr-2017

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2017 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2017.

PHARMAID 24-Jan-2017

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 26, 2017 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2016.

PHARMAID 09-Nov-2016

The Board of Directors has recommended 30% cash dividend for the year ended on June 30, 2016. Date of AGM: 29.12.2016, Time: 11:00 AM, Venue: Kendrio Kanchi Kancher Mela Auditorium, 37/A Segun Bagicha, Dhaka-1000. Record date: 04.12.2016. The Company has also reported EPS of Tk. 7.52, NAV per share of Tk. 42.45 and NOCFPS of Tk. 3.89 for the year ended on June 30, 2016 as against Tk. 8.16, Tk. 37.43 and Tk. 1.11 respectively for the same period of the previous year.

PHARMAID 08-Nov-2016

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2016 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2016.

PHARMAID 02-Nov-2016

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 08, 2016 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2016.

Previous Next page